While the reduction in serum cPL immunoreactivity (cPLI) concentration is associated with enhanced clinical outcomes in dogs hospitalized with acute pancreatitis, the utilization of serial serum cPLI as an objective biomarker for monitoring clinical alterations in hospitalized dogs with acute pancreatitis necessitates further investigation. This evidence concerns the gene HEPH and acute pancreatitis.